Biochemical ‘fingerprints’ of Barth syndrome include mitochondrial cardiolipin deficiency in cardiac muscle cells [52], increased levels of monolysocardiolipin, altered alkyl chains of cardiolipin [53,54], and tafazzin deficiency [49]. This evidence concerns the gene TAFAZZIN and Barth syndrome.